Changing patterns of ocular manifestations in HIV seropositive patients treated with HAART

To report the changing patterns of ocular manifestations in human immunodeficiency virus (HIV) seropositive patients treated with highly active antiretroviral therapy (HAART). The clinical charts of HIV seropositive patients, 735 examined from 1997 to 2003 and treated with HAART for at least 2 month...

Full description

Saved in:
Bibliographic Details
Published in:European journal of ophthalmology 2006-09, Vol.16 (5), p.728-732
Main Authors: Accorinti, M, Pirraglia, M P, Corradi, R, Corsi, C, Fabiani, C, Pivetti-Pezzi, P
Format: Article
Language:English
Subjects:
Adolescent
Adult
Aged
Antiretroviral Therapy, Highly Active - methods
Child
Child, Preschool
Eye Diseases - epidemiology
Eye Diseases - etiology
Female
Follow-Up Studies
HIV Seropositivity - complications
HIV Seropositivity - drug therapy
Humans
Incidence
Infant
Male
Middle Aged
Prognosis
Retrospective Studies
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c301t-9b151f13cae1430070ab76e28afdc4d00e3e0bab48106fee34bea6d71e09a5ae3
cites cdi_FETCH-LOGICAL-c301t-9b151f13cae1430070ab76e28afdc4d00e3e0bab48106fee34bea6d71e09a5ae3
container_end_page 732
container_issue 5
container_start_page 728
container_title European journal of ophthalmology
container_volume 16
creator Accorinti, M
Pirraglia, M P
Corradi, R
Corsi, C
Fabiani, C
Pivetti-Pezzi, P
description To report the changing patterns of ocular manifestations in human immunodeficiency virus (HIV) seropositive patients treated with highly active antiretroviral therapy (HAART). The clinical charts of HIV seropositive patients, 735 examined from 1997 to 2003 and treated with HAART for at least 2 months (Group 1), and 838 untreated examined from 1988 to 1995 (Group 2), were reviewed to assess the frequency of ocular manifestations. HIV-related retinal microangiopathy and opportunistic retinal infections (cytomegalovirus retinitis and toxoplasmic retinochoroiditis) were significantly higher in Group 2 than 1 (p
doi_str_mv 10.1177/112067210601600511
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68989668</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68989668</sourcerecordid><originalsourceid>FETCH-LOGICAL-c301t-9b151f13cae1430070ab76e28afdc4d00e3e0bab48106fee34bea6d71e09a5ae3</originalsourceid><addsrcrecordid>eNplkE9Lw0AQxRdRbK1-AQ-yJ2_RmU2ymxxLUVsoCFI9eAmbZNKu5J-7W8Vvb0ILHjzNMPN7j5nH2DXCHaJS94gCpBIIElACxIgnbIpKRME4OB36AQhGYsIunPsAEJBG4pxNUIFEIeIpe1_sdLs17Zb32nuyreNdxbtiX2vLG92aipzX3nTDwrR8uXrjjmzXd85480WjylDrHfeWtKeSfxu_48v5_GVzyc4qXTu6OtYZe3182CyWwfr5abWYr4MiBPRBmmOMFYaFJoxCAAU6V5JEoquyiEoACglynUfJ8GhFFEY5aVkqJEh1rCmcsduDb2-7z_1wbtYYV1Bd65a6vctkkiaplMkAigNY2M45S1XWW9No-5MhZGOi2f9EB9HN0X2fN1T-SY4Rhr8X0HF_</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68989668</pqid></control><display><type>article</type><title>Changing patterns of ocular manifestations in HIV seropositive patients treated with HAART</title><source>SAGE</source><creator>Accorinti, M ; Pirraglia, M P ; Corradi, R ; Corsi, C ; Fabiani, C ; Pivetti-Pezzi, P</creator><creatorcontrib>Accorinti, M ; Pirraglia, M P ; Corradi, R ; Corsi, C ; Fabiani, C ; Pivetti-Pezzi, P</creatorcontrib><description>To report the changing patterns of ocular manifestations in human immunodeficiency virus (HIV) seropositive patients treated with highly active antiretroviral therapy (HAART). The clinical charts of HIV seropositive patients, 735 examined from 1997 to 2003 and treated with HAART for at least 2 months (Group 1), and 838 untreated examined from 1988 to 1995 (Group 2), were reviewed to assess the frequency of ocular manifestations. HIV-related retinal microangiopathy and opportunistic retinal infections (cytomegalovirus retinitis and toxoplasmic retinochoroiditis) were significantly higher in Group 2 than 1 (p&lt;0.0001), while in patients treated with HAART a statistically significant increase in the frequency of chalazion (p&lt;0.0001), diabetic and hypertensive retinopathy (p&lt;0.0001), lipid arc of the cornea (p&lt;0.0001), cataract and glaucoma (p&lt;0.0001), and uveitis (p=0.026) was observed. HAART therapy has induced a dramatic decrease in the incidence of HIV-related microangiopathy and opportunistic retinal infection and the occurrence of new lesions related both to the metabolic alterations induced by HAART and to immune reconstitution, such as uveitis.</description><identifier>ISSN: 1120-6721</identifier><identifier>EISSN: 1724-6016</identifier><identifier>DOI: 10.1177/112067210601600511</identifier><identifier>PMID: 17061225</identifier><language>eng</language><publisher>United States</publisher><subject>Adolescent ; Adult ; Aged ; Antiretroviral Therapy, Highly Active - methods ; Child ; Child, Preschool ; Eye Diseases - epidemiology ; Eye Diseases - etiology ; Female ; Follow-Up Studies ; HIV Seropositivity - complications ; HIV Seropositivity - drug therapy ; Humans ; Incidence ; Infant ; Male ; Middle Aged ; Prognosis ; Retrospective Studies</subject><ispartof>European journal of ophthalmology, 2006-09, Vol.16 (5), p.728-732</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c301t-9b151f13cae1430070ab76e28afdc4d00e3e0bab48106fee34bea6d71e09a5ae3</citedby><cites>FETCH-LOGICAL-c301t-9b151f13cae1430070ab76e28afdc4d00e3e0bab48106fee34bea6d71e09a5ae3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17061225$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Accorinti, M</creatorcontrib><creatorcontrib>Pirraglia, M P</creatorcontrib><creatorcontrib>Corradi, R</creatorcontrib><creatorcontrib>Corsi, C</creatorcontrib><creatorcontrib>Fabiani, C</creatorcontrib><creatorcontrib>Pivetti-Pezzi, P</creatorcontrib><title>Changing patterns of ocular manifestations in HIV seropositive patients treated with HAART</title><title>European journal of ophthalmology</title><addtitle>Eur J Ophthalmol</addtitle><description>To report the changing patterns of ocular manifestations in human immunodeficiency virus (HIV) seropositive patients treated with highly active antiretroviral therapy (HAART). The clinical charts of HIV seropositive patients, 735 examined from 1997 to 2003 and treated with HAART for at least 2 months (Group 1), and 838 untreated examined from 1988 to 1995 (Group 2), were reviewed to assess the frequency of ocular manifestations. HIV-related retinal microangiopathy and opportunistic retinal infections (cytomegalovirus retinitis and toxoplasmic retinochoroiditis) were significantly higher in Group 2 than 1 (p&lt;0.0001), while in patients treated with HAART a statistically significant increase in the frequency of chalazion (p&lt;0.0001), diabetic and hypertensive retinopathy (p&lt;0.0001), lipid arc of the cornea (p&lt;0.0001), cataract and glaucoma (p&lt;0.0001), and uveitis (p=0.026) was observed. HAART therapy has induced a dramatic decrease in the incidence of HIV-related microangiopathy and opportunistic retinal infection and the occurrence of new lesions related both to the metabolic alterations induced by HAART and to immune reconstitution, such as uveitis.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Antiretroviral Therapy, Highly Active - methods</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Eye Diseases - epidemiology</subject><subject>Eye Diseases - etiology</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>HIV Seropositivity - complications</subject><subject>HIV Seropositivity - drug therapy</subject><subject>Humans</subject><subject>Incidence</subject><subject>Infant</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Prognosis</subject><subject>Retrospective Studies</subject><issn>1120-6721</issn><issn>1724-6016</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><recordid>eNplkE9Lw0AQxRdRbK1-AQ-yJ2_RmU2ymxxLUVsoCFI9eAmbZNKu5J-7W8Vvb0ILHjzNMPN7j5nH2DXCHaJS94gCpBIIElACxIgnbIpKRME4OB36AQhGYsIunPsAEJBG4pxNUIFEIeIpe1_sdLs17Zb32nuyreNdxbtiX2vLG92aipzX3nTDwrR8uXrjjmzXd85480WjylDrHfeWtKeSfxu_48v5_GVzyc4qXTu6OtYZe3182CyWwfr5abWYr4MiBPRBmmOMFYaFJoxCAAU6V5JEoquyiEoACglynUfJ8GhFFEY5aVkqJEh1rCmcsduDb2-7z_1wbtYYV1Bd65a6vctkkiaplMkAigNY2M45S1XWW9No-5MhZGOi2f9EB9HN0X2fN1T-SY4Rhr8X0HF_</recordid><startdate>20060901</startdate><enddate>20060901</enddate><creator>Accorinti, M</creator><creator>Pirraglia, M P</creator><creator>Corradi, R</creator><creator>Corsi, C</creator><creator>Fabiani, C</creator><creator>Pivetti-Pezzi, P</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20060901</creationdate><title>Changing patterns of ocular manifestations in HIV seropositive patients treated with HAART</title><author>Accorinti, M ; Pirraglia, M P ; Corradi, R ; Corsi, C ; Fabiani, C ; Pivetti-Pezzi, P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c301t-9b151f13cae1430070ab76e28afdc4d00e3e0bab48106fee34bea6d71e09a5ae3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Antiretroviral Therapy, Highly Active - methods</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Eye Diseases - epidemiology</topic><topic>Eye Diseases - etiology</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>HIV Seropositivity - complications</topic><topic>HIV Seropositivity - drug therapy</topic><topic>Humans</topic><topic>Incidence</topic><topic>Infant</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Prognosis</topic><topic>Retrospective Studies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Accorinti, M</creatorcontrib><creatorcontrib>Pirraglia, M P</creatorcontrib><creatorcontrib>Corradi, R</creatorcontrib><creatorcontrib>Corsi, C</creatorcontrib><creatorcontrib>Fabiani, C</creatorcontrib><creatorcontrib>Pivetti-Pezzi, P</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of ophthalmology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Accorinti, M</au><au>Pirraglia, M P</au><au>Corradi, R</au><au>Corsi, C</au><au>Fabiani, C</au><au>Pivetti-Pezzi, P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Changing patterns of ocular manifestations in HIV seropositive patients treated with HAART</atitle><jtitle>European journal of ophthalmology</jtitle><addtitle>Eur J Ophthalmol</addtitle><date>2006-09-01</date><risdate>2006</risdate><volume>16</volume><issue>5</issue><spage>728</spage><epage>732</epage><pages>728-732</pages><issn>1120-6721</issn><eissn>1724-6016</eissn><abstract>To report the changing patterns of ocular manifestations in human immunodeficiency virus (HIV) seropositive patients treated with highly active antiretroviral therapy (HAART). The clinical charts of HIV seropositive patients, 735 examined from 1997 to 2003 and treated with HAART for at least 2 months (Group 1), and 838 untreated examined from 1988 to 1995 (Group 2), were reviewed to assess the frequency of ocular manifestations. HIV-related retinal microangiopathy and opportunistic retinal infections (cytomegalovirus retinitis and toxoplasmic retinochoroiditis) were significantly higher in Group 2 than 1 (p&lt;0.0001), while in patients treated with HAART a statistically significant increase in the frequency of chalazion (p&lt;0.0001), diabetic and hypertensive retinopathy (p&lt;0.0001), lipid arc of the cornea (p&lt;0.0001), cataract and glaucoma (p&lt;0.0001), and uveitis (p=0.026) was observed. HAART therapy has induced a dramatic decrease in the incidence of HIV-related microangiopathy and opportunistic retinal infection and the occurrence of new lesions related both to the metabolic alterations induced by HAART and to immune reconstitution, such as uveitis.</abstract><cop>United States</cop><pmid>17061225</pmid><doi>10.1177/112067210601600511</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1120-6721
ispartof European journal of ophthalmology, 2006-09, Vol.16 (5), p.728-732
issn 1120-6721
1724-6016
language eng
recordid cdi_proquest_miscellaneous_68989668
source SAGE
subjects Adolescent
Adult
Aged
Antiretroviral Therapy, Highly Active - methods
Child
Child, Preschool
Eye Diseases - epidemiology
Eye Diseases - etiology
Female
Follow-Up Studies
HIV Seropositivity - complications
HIV Seropositivity - drug therapy
Humans
Incidence
Infant
Male
Middle Aged
Prognosis
Retrospective Studies
title Changing patterns of ocular manifestations in HIV seropositive patients treated with HAART
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-30T21%3A46%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Changing%20patterns%20of%20ocular%20manifestations%20in%20HIV%20seropositive%20patients%20treated%20with%20HAART&rft.jtitle=European%20journal%20of%20ophthalmology&rft.au=Accorinti,%20M&rft.date=2006-09-01&rft.volume=16&rft.issue=5&rft.spage=728&rft.epage=732&rft.pages=728-732&rft.issn=1120-6721&rft.eissn=1724-6016&rft_id=info:doi/10.1177/112067210601600511&rft_dat=%3Cproquest_cross%3E68989668%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c301t-9b151f13cae1430070ab76e28afdc4d00e3e0bab48106fee34bea6d71e09a5ae3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=68989668&rft_id=info:pmid/17061225&rfr_iscdi=true